462 related articles for article (PubMed ID: 20200425)
61. Methylator phenotype in colorectal cancer: A prognostic factor or not?
Gallois C; Laurent-Puig P; Taieb J
Crit Rev Oncol Hematol; 2016 Mar; 99():74-80. PubMed ID: 26702883
[TBL] [Abstract][Full Text] [Related]
62. Relationship of CDX2 loss with molecular features and prognosis in colorectal cancer.
Baba Y; Nosho K; Shima K; Freed E; Irahara N; Philips J; Meyerhardt JA; Hornick JL; Shivdasani RA; Fuchs CS; Ogino S
Clin Cancer Res; 2009 Jul; 15(14):4665-73. PubMed ID: 19584150
[TBL] [Abstract][Full Text] [Related]
63. Differential clinicopathological features in microsatellite instability-positive colorectal cancers depending on CIMP status.
Bae JM; Kim MJ; Kim JH; Koh JM; Cho NY; Kim TY; Kang GH
Virchows Arch; 2011 Jul; 459(1):55-63. PubMed ID: 21494758
[TBL] [Abstract][Full Text] [Related]
64. Association Between Molecular Subtypes of Colorectal Tumors and Patient Survival, Based on Pooled Analysis of 7 International Studies.
Phipps AI; Alwers E; Harrison T; Banbury B; Brenner H; Campbell PT; Chang-Claude J; Buchanan D; Chan AT; Farris AB; Figueiredo JC; Gallinger S; Giles GG; Jenkins M; Milne RL; Newcomb PA; Slattery ML; Song M; Ogino S; Zaidi SH; Hoffmeister M; Peters U
Gastroenterology; 2020 Jun; 158(8):2158-2168.e4. PubMed ID: 32088204
[TBL] [Abstract][Full Text] [Related]
65. Prognostic implication of the CpG island methylator phenotype in colorectal cancers depends on tumour location.
Bae JM; Kim JH; Cho NY; Kim TY; Kang GH
Br J Cancer; 2013 Aug; 109(4):1004-12. PubMed ID: 23900220
[TBL] [Abstract][Full Text] [Related]
66. Aberrant TET1 Methylation Closely Associated with CpG Island Methylator Phenotype in Colorectal Cancer.
Ichimura N; Shinjo K; An B; Shimizu Y; Yamao K; Ohka F; Katsushima K; Hatanaka A; Tojo M; Yamamoto E; Suzuki H; Ueda M; Kondo Y
Cancer Prev Res (Phila); 2015 Aug; 8(8):702-11. PubMed ID: 26063725
[TBL] [Abstract][Full Text] [Related]
67. Prognostic implications of CpG island hypermethylator phenotype in colorectal cancers.
Kim JH; Shin SH; Kwon HJ; Cho NY; Kang GH
Virchows Arch; 2009 Dec; 455(6):485-94. PubMed ID: 19911194
[TBL] [Abstract][Full Text] [Related]
68. Prognostic significance and molecular associations of 18q loss of heterozygosity: a cohort study of microsatellite stable colorectal cancers.
Ogino S; Nosho K; Irahara N; Shima K; Baba Y; Kirkner GJ; Meyerhardt JA; Fuchs CS
J Clin Oncol; 2009 Sep; 27(27):4591-8. PubMed ID: 19704056
[TBL] [Abstract][Full Text] [Related]
69. Clinical and prognosis value of the CIMP status combined with MLH1 or p16
Saadallah-Kallel A; Abdelmaksoud-Dammak R; Triki M; Charfi S; Khabir A; Sallemi-Boudawara T; Mokdad-Gargouri R
Med Oncol; 2017 Aug; 34(8):147. PubMed ID: 28730335
[TBL] [Abstract][Full Text] [Related]
70. STAT3 expression, molecular features, inflammation patterns, and prognosis in a database of 724 colorectal cancers.
Morikawa T; Baba Y; Yamauchi M; Kuchiba A; Nosho K; Shima K; Tanaka N; Huttenhower C; Frank DA; Fuchs CS; Ogino S
Clin Cancer Res; 2011 Mar; 17(6):1452-62. PubMed ID: 21310826
[TBL] [Abstract][Full Text] [Related]
71. Microsatellite instability and survival in rectal cancer.
Samowitz WS; Curtin K; Wolff RK; Tripp SR; Caan BJ; Slattery ML
Cancer Causes Control; 2009 Nov; 20(9):1763-8. PubMed ID: 19669908
[TBL] [Abstract][Full Text] [Related]
72. CpG island methylator phenotype is an independent predictor of survival after curative resection for colorectal cancer: A prospective cohort study.
Kim CH; Huh JW; Kim HR; Kim YJ
J Gastroenterol Hepatol; 2017 Aug; 32(8):1469-1474. PubMed ID: 28087988
[TBL] [Abstract][Full Text] [Related]
73. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis.
Mima K; Nishihara R; Qian ZR; Cao Y; Sukawa Y; Nowak JA; Yang J; Dou R; Masugi Y; Song M; Kostic AD; Giannakis M; Bullman S; Milner DA; Baba H; Giovannucci EL; Garraway LA; Freeman GJ; Dranoff G; Garrett WS; Huttenhower C; Meyerson M; Meyerhardt JA; Chan AT; Fuchs CS; Ogino S
Gut; 2016 Dec; 65(12):1973-1980. PubMed ID: 26311717
[TBL] [Abstract][Full Text] [Related]
74. B vitamins, methionine and alcohol intake and risk of colon cancer in relation to BRAF mutation and CpG island methylator phenotype (CIMP).
Schernhammer ES; Giovannucci E; Baba Y; Fuchs CS; Ogino S
PLoS One; 2011; 6(6):e21102. PubMed ID: 21738611
[TBL] [Abstract][Full Text] [Related]
75. Microsatellite instability and BRAF mutation testing in colorectal cancer prognostication.
Lochhead P; Kuchiba A; Imamura Y; Liao X; Yamauchi M; Nishihara R; Qian ZR; Morikawa T; Shen J; Meyerhardt JA; Fuchs CS; Ogino S
J Natl Cancer Inst; 2013 Aug; 105(15):1151-6. PubMed ID: 23878352
[TBL] [Abstract][Full Text] [Related]
76. Subsets of microsatellite-unstable colorectal cancers exhibit discordance between the CpG island methylator phenotype and MLH1 methylation status.
Kim JH; Rhee YY; Bae JM; Kwon HJ; Cho NY; Kim MJ; Kang GH
Mod Pathol; 2013 Jul; 26(7):1013-22. PubMed ID: 23370766
[TBL] [Abstract][Full Text] [Related]
77. Isocitrate dehydrogenase 1 R132C mutation occurs exclusively in microsatellite stable colorectal cancers with the CpG island methylator phenotype.
Whitehall VL; Dumenil TD; McKeone DM; Bond CE; Bettington ML; Buttenshaw RL; Bowdler L; Montgomery GW; Wockner LF; Leggett BA
Epigenetics; 2014 Nov; 9(11):1454-60. PubMed ID: 25496513
[TBL] [Abstract][Full Text] [Related]
78. BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancer.
Chen KH; Lin YL; Liau JY; Tsai JH; Tseng LH; Lin LI; Liang JT; Lin BR; Hung JS; Chang YL; Yeh KH; Cheng AL
Med Oncol; 2016 May; 33(5):39. PubMed ID: 27034263
[TBL] [Abstract][Full Text] [Related]
79. Tumor LINE-1 methylation level and microsatellite instability in relation to colorectal cancer prognosis.
Inamura K; Yamauchi M; Nishihara R; Lochhead P; Qian ZR; Kuchiba A; Kim SA; Mima K; Sukawa Y; Jung S; Zhang X; Wu K; Cho E; Chan AT; Meyerhardt JA; Harris CC; Fuchs CS; Ogino S
J Natl Cancer Inst; 2014 Sep; 106(9):. PubMed ID: 25190725
[TBL] [Abstract][Full Text] [Related]
80. Meta-analysis of the molecular associations of mucinous colorectal cancer.
Reynolds IS; Furney SJ; Kay EW; McNamara DA; Prehn JHM; Burke JP
Br J Surg; 2019 May; 106(6):682-691. PubMed ID: 30945755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
